Amiodarone-related thyroid dysfunction and associated outcomes in patients with heart failure - a matched case-control study

1 September 2024 (10:00 - 10:50)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Sam Aiyad Ali

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

8 More presentations in this session

Presentation thumbnail

Efficacy and safety of ultrasound guided stellate ganglion block: developing new clinical indications beyond electrical storm

Doctor A. Morena (Pavia, IT)

Abstract Slides Video

Presentation thumbnail

Atrial and ventricular arrhythmias in young, lifelong and retired elite endurance athletes

Doctor P. D'Ambrosio (Fitzroy, AU)

Abstract Slides Video

Presentation thumbnail

Analysis of safety and outcome of use of NOAC in intracardiac thrombi over warfarin

Doctor O. Al-assaf (Dubai, AE)

Abstract Slides Video

Presentation thumbnail

Association between preprocedural thromboembolic or bleeding events under oral anticoagulation therapy and mid-term outcomes after percutaneous left atrial appendage closure

Doctor H. Sumiyoshi (Kamogawa, JP)

Abstract Slides Video

Presentation thumbnail

BA6b9, a novel sk4 K + channel blocker, attenuates atrial fibrillation substrate in rats with reduced ejection fraction

Mr O. Levi (Beer Sheva, IL)

Abstract Slides Video

Access the full session

Session thumbnail

Clinical and experimental arrhythmia treatments

The Event

Event poster

ESC Congress 2024

1 September 2024 10:00 CET

You may be interested in

Congress Presentation

Prognostic impact of thyroid dysfunction in patients with incident heart failure: a nationwide study

Congress Presentation

Amiodarone induced thyroid dysfunction.

Congress Presentation

Amiodarone and the risk for pulmonary fibrosis. A Danish nationwide study.

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources